87 related articles for article (PubMed ID: 26607501)
21. Paradoxically abundant expression of Bcl-2 and adrenomedullin in invasive cervical squamous carcinoma.
Li Z; Takeuchi S; Ohara N; Maruo T
Int J Clin Oncol; 2003 Apr; 8(2):83-9. PubMed ID: 12720100
[TBL] [Abstract][Full Text] [Related]
22. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
Shi HR; Wu QH; Suo ZH; Nesland JM
Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation changes in cervical cancers.
Lu Q; Ma D; Zhao S
Methods Mol Biol; 2012; 863():155-76. PubMed ID: 22359292
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic control of MAGE gene expression by the KIT tyrosine kinase.
Yang B; Wu J; Maddodi N; Ma Y; Setaluri V; Longley BJ
J Invest Dermatol; 2007 Sep; 127(9):2123-8. PubMed ID: 17495964
[TBL] [Abstract][Full Text] [Related]
25. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
[TBL] [Abstract][Full Text] [Related]
27. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
Kang S; Kim JW; Kang GH; Lee S; Park NH; Song YS; Park SY; Kang SB; Lee HP
Int J Cancer; 2006 May; 118(9):2168-71. PubMed ID: 16331610
[TBL] [Abstract][Full Text] [Related]
28. An epigenetic switch is crucial for spermatogonia to exit the undifferentiated state toward a Kit-positive identity.
Shirakawa T; Yaman-Deveci R; Tomizawa S; Kamizato Y; Nakajima K; Sone H; Sato Y; Sharif J; Yamashita A; Takada-Horisawa Y; Yoshida S; Ura K; Muto M; Koseki H; Suda T; Ohbo K
Development; 2013 Sep; 140(17):3565-76. PubMed ID: 23903187
[TBL] [Abstract][Full Text] [Related]
29. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kokawa K; Shikone T; Otani T; Nakano R
Cancer; 1999 Apr; 85(8):1799-809. PubMed ID: 10223575
[TBL] [Abstract][Full Text] [Related]
31. Epigenome and DNA methylation in oral squamous cell carcinoma.
García MP; García-García A
Methods Mol Biol; 2012; 863():207-19. PubMed ID: 22359295
[TBL] [Abstract][Full Text] [Related]
32. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
[TBL] [Abstract][Full Text] [Related]
33. High expressions of bcl-2 and survivin, and decreased apoptosis in uterine cervical carcinosarcoma compared to cervical squamous cell carcinoma.
Gan XL; Li JK; Yu TH; Zhang Y; Hu LN
Arch Gynecol Obstet; 2011 Jul; 284(1):175-81. PubMed ID: 20668868
[TBL] [Abstract][Full Text] [Related]
34. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
[TBL] [Abstract][Full Text] [Related]
36. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
[TBL] [Abstract][Full Text] [Related]
37. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
38. Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
Mozzetti S; Ferrandina G; Marone M; D'Ingiullo F; Fruscella E; De Pasqua A; Mancuso S; Scambia G
Cancer Detect Prev; 2000; 24(6):536-41. PubMed ID: 11198267
[TBL] [Abstract][Full Text] [Related]
39. Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil.
Borges Bdo N; Santos Eda S; Bastos CE; Pinto LC; Anselmo NP; Quaresma JA; Calcagno DQ; Burbano RM; Harada ML
Anticancer Res; 2010 Jun; 30(6):2225-33. PubMed ID: 20651373
[TBL] [Abstract][Full Text] [Related]
40. KIT gene exon 11 mutations in canine malignant melanoma.
Chu PY; Pan SL; Liu CH; Lee J; Yeh LS; Liao AT
Vet J; 2013 May; 196(2):226-30. PubMed ID: 23069279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
